Cerdelga
NDC 58468-0220, eliglustat, capsule, from Genzyme Corporation.
- Product NDC
- 58468-0220
- Status
- Listed
- Labeler
- Genzyme Corporation
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205494
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELIGLUSTAT84 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58468-0220-1 | 58468022001 | 4 BLISTER PACK in 1 CARTON (58468-0220-1) / 14 CAPSULE in 1 BLISTER PACK |
| 58468-0220-2 | 58468022002 | 1 BLISTER PACK in 1 CARTON (58468-0220-2) / 14 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/819f828a-b888-4e46-83fc-94d774a28a83
Use it
Look up 58468-0220 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58468-0220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.